Search Results - "Burkey, Bryan F."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    This result is not displayed to guests.

    Save to List
  2. 2

    FIRST-IN-CLASS ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR LCZ696 MODULATES THE DYNAMICS OF THE RENIN CASCADE AND NATRIURETIC PEPTIDES SYSTEM WITH SIGNIFICANT REDUCTION OF ALDOSTERONE EXPOSURE.

    Authors: Mochel, Jonathan Burkey, Bryan F. Fink, Martin et al.

    Source: Journal of the American College of Cardiology (JACC). Apr2014 Supplement, Vol. 63, pA806-A806. 1p.

    Save to List
  3. 3

    Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study.

    Authors: Mi-Jeong Lee Da-Wei Gong Burkey, Bryan F. et al.

    Source: American Journal of Physiology: Endocrinology & Metabolism. Mar2011, Vol. 300, pE571-E580. 10p.

    PDF Full Text
    Save to List
  4. 4

    The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats

    Authors: Duttaroy, Alokesh Voelker, Frank Merriam, Kimberley et al.

    Source: European Journal of Pharmacology. Jan2011, Vol. 650 Issue 2/3, p703-707. 5p.

    Save to List
  5. 5

    Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.

    Authors: de Souza, Christopher J. Eckhardt, Michele Gagen, Karen et al.

    Source: Diabetes. Aug2001, Vol. 50 Issue 8, p1863-1871. 9p. 1 Black and White Photograph, 1 Diagram, 4 Charts, 4 Graphs.

    HTML Full Text PDF Full Text
    Save to List
  6. 6

    MetAP2 inhibition reduces food intake and body weight in a ciliopathy mouse model of obesity.

    Authors: Pottorf TS Fagan MP Burkey BF et al.

    Source: JCI insight [JCI Insight] 2020 Jan 30; Vol. 5 (2). Date of Electronic Publication: 2020 Jan 30.

    Publication Type: Journal Article

    Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

    Save to List
  7. 7

    Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061.

    Authors: Burkey BF Hoglen NC Inskeep P et al.

    Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 May; Vol. 365 (2), pp. 301-313. Date of Electronic Publication: 2018 Feb 28.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

    Save to List
  8. 8

    1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.

    Authors: Villhauer EB Brinkman JA Naderi GB et al.

    Source: Journal of medicinal chemistry [J Med Chem] 2003 Jun 19; Vol. 46 (13), pp. 2774-89.

    Publication Type: Journal Article

    Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print Cited Medium: Print ISSN: 0022-2623 (Print) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

    Save to List

Search Tools: